IndiaTickerLatest filing: IOL Chemicals & Pharmaceuticals Ltd - 524164 - Board Meeting Intimation for Notice Of Board Meeting
ObservedCompany dossier
IOL Chemicals & Pharmaceuticals
NSE:IOLCP · ISIN INE485C01029
- Close
- Unavailable Date unavailable
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
IOL Chemicals & Pharmaceuticals
Overview
Evidence state
Coverage in progressCompany record at a glance
Latest reported period: 31 Dec 2024 · revenue ₹523.3 Cr · PAT ₹20.5 Cr.
Exchange XBRLLatest ownership: promoter group 62.28% and public 37.72% as of 30 Jun 2026.
Exchange XBRLMaterial events
Open timeline →What changed recently
Observed
Source filing IOL Chemicals & Pharmaceuticals Ltd - 524164 - Board Meeting Intimation for Notice Of Board Meeting
BSE · exchange filing
Observed
Source filing IOL Chemicals & Pharmaceuticals Ltd - 524164 - Announcement under Regulation 30 (LODR)-Newspaper Publication
BSE · exchange filing
Observed
Source filing General Updates - IOL Chemicals and Pharmaceuticals Limited
NSE · exchange filing
Observed
Source filing IOL Chemicals & Pharmaceuticals Ltd - 524164 - Approval From NMPA, China For Clopidogrel Bisulfate API
BSE · exchange filing
Reported financials
Full financials →31 Dec 2024
- Revenue from operations
- ₹523.3 Cr
- Profit after tax
- ₹20.5 Cr
- EPS
- ₹3.50
Observed NSE structured filing · Consolidated
Ownership
Full shareholding →30 Jun 2026
- Promoter group
- 62.28%
- Public
- 37.72%
- Employee trust
- 0.00%
Observed NSE shareholding XBRL